首页 > 最新文献

Urologia Journal最新文献

英文 中文
Physical activity after single incision sling for stress urinary incontinence: Our experience. 单切口悬吊治疗压力性尿失禁后的身体活动:我们的经验。
IF 0.7 Q4 UROLOGY & NEPHROLOGY Pub Date : 2026-03-05 DOI: 10.1177/03915603261426554
Andrea Morciano, Giovanni Pecorella, Andrea Tinelli, Giuseppe Marzo, Michele Carlo Schiavi, Matteo Frigerio, Giuseppe Campagna, Mauro Cervigni, Francesco Fanfani, Anna Fagotti

Objectives: The post-operative management of patients undergoing urogynecologic surgery remains controversial, despite the adoption of enhanced recovery protocols. This study aimed to evaluate the influence of moderate-to-high physical activity on functional and subjective outcomes after implantation of the Altis® single-incision sling, with an 18-month follow-up (FU).

Methods: A total of 222 consecutive women treated for stress urinary incontinence (SUI) between December 2019 and March 2022 were retrospectively reviewed. At 3-month FU, participants completed the International physical activity Questionnaire-Short Form (IPAQ-SF). Based on IPAQ-SF results, patients were categorized into Low or Moderate-High activity groups. Objective and subjective outcomes were compared at 3 and 18 months.

Results: Both activity groups achieved high objective and subjective success rates, with no statistically significant differences at either follow-up interval. These results were maintained at 18 months. No correlation emerged in functional or objective results between activity level and surgical outcomes.

Conclusion: Moderate or high post-operative physical activity did not adversely affect functional or patient-reported outcomes after Altis® sling implantation. These findings support the Enhanced Recovery After Surgery (ERAS) philosophy and highlight the importance of abandoning unnecessary post-operative rest recommendations following SUI surgery.

目的:尽管采用了增强恢复方案,但泌尿妇科手术患者的术后管理仍然存在争议。本研究旨在通过18个月的随访,评估中至高强度体育活动对Altis®单切口吊带植入后功能和主观结果的影响。方法:对2019年12月至2022年3月期间222例连续接受压力性尿失禁(SUI)治疗的女性患者进行回顾性分析。在FU 3个月时,参与者完成国际体育活动问卷-短表(IPAQ-SF)。根据IPAQ-SF结果,将患者分为低活动组和中高活动组。在3个月和18个月时比较客观和主观结果。结果:两组活动均获得较高的客观和主观成功率,两组随访时间无统计学差异。这些结果在18个月后保持不变。活动水平与手术结果之间的功能或客观结果没有相关性。结论:中度或高度的术后体力活动对Altis®吊带植入后的功能或患者报告的结果没有不利影响。这些发现支持了ERAS的理念,并强调了在SUI手术后放弃不必要的术后休息建议的重要性。
{"title":"Physical activity after single incision sling for stress urinary incontinence: Our experience.","authors":"Andrea Morciano, Giovanni Pecorella, Andrea Tinelli, Giuseppe Marzo, Michele Carlo Schiavi, Matteo Frigerio, Giuseppe Campagna, Mauro Cervigni, Francesco Fanfani, Anna Fagotti","doi":"10.1177/03915603261426554","DOIUrl":"https://doi.org/10.1177/03915603261426554","url":null,"abstract":"<p><strong>Objectives: </strong>The post-operative management of patients undergoing urogynecologic surgery remains controversial, despite the adoption of enhanced recovery protocols. This study aimed to evaluate the influence of moderate-to-high physical activity on functional and subjective outcomes after implantation of the Altis<sup>®</sup> single-incision sling, with an 18-month follow-up (<i>FU</i>).</p><p><strong>Methods: </strong>A total of 222 consecutive women treated for stress urinary incontinence (<i>SUI</i>) between December 2019 and March 2022 were retrospectively reviewed. At 3-month <i>FU</i>, participants completed the International physical activity Questionnaire-Short Form (IPAQ-SF). Based on IPAQ-SF results, patients were categorized into <i>Low</i> or <i>Moderate-High</i> activity groups. Objective and subjective outcomes were compared at 3 and 18 months.</p><p><strong>Results: </strong>Both activity groups achieved high objective and subjective success rates, with no statistically significant differences at either follow-up interval. These results were maintained at 18 months. No correlation emerged in functional or objective results between activity level and surgical outcomes.</p><p><strong>Conclusion: </strong>Moderate or high post-operative physical activity did not adversely affect functional or patient-reported outcomes after Altis<sup>®</sup> sling implantation. These findings support the Enhanced Recovery After Surgery (<i>ERAS</i>) philosophy and highlight the importance of abandoning unnecessary post-operative rest recommendations following <i>SUI</i> surgery.</p>","PeriodicalId":23574,"journal":{"name":"Urologia Journal","volume":" ","pages":"3915603261426554"},"PeriodicalIF":0.7,"publicationDate":"2026-03-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147356381","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Evaluation of urethral stricture score (USS) in predicting intraoperative complexity and postoperative outcome in anterior urethral stricture: An observational study. 评价尿道狭窄评分(USS)在预测前尿道狭窄术中复杂性和术后预后中的作用:一项观察性研究。
IF 0.7 Q4 UROLOGY & NEPHROLOGY Pub Date : 2026-02-27 DOI: 10.1177/03915603261427630
Berk Yasin Ekenci
{"title":"Evaluation of urethral stricture score (USS) in predicting intraoperative complexity and postoperative outcome in anterior urethral stricture: An observational study.","authors":"Berk Yasin Ekenci","doi":"10.1177/03915603261427630","DOIUrl":"https://doi.org/10.1177/03915603261427630","url":null,"abstract":"","PeriodicalId":23574,"journal":{"name":"Urologia Journal","volume":" ","pages":"3915603261427630"},"PeriodicalIF":0.7,"publicationDate":"2026-02-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147318315","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Tadalafil and tamsulosin in the management of lower urinary tract symptoms due to benign prostatic hyperplasia: A prospective, randomized, open-label, comparative study. 他达拉非和坦索罗辛治疗良性前列腺增生引起的下尿路症状:一项前瞻性、随机、开放标签的比较研究
IF 0.7 Q4 UROLOGY & NEPHROLOGY Pub Date : 2026-02-15 DOI: 10.1177/03915603261421800
Enoch Tackie, Mathew Yamoah Kyei, James Edward Mensah

Background: Benign prostatic hyperplasia (BPH) commonly presents with lower urinary tract symptoms (LUTS), which can significantly impair quality of life in aging men. Tamsulosin, a selective alpha-1 blocker, is widely used for symptom relief. Tadalafil, a phosphodiesterase-5 inhibitor, offers dual benefit for LUTS and erectile dysfunction (ED). However, limited comparative data exist from African populations.

Objective: To compare the efficacy and safety of tadalafil and tamsulosin monotherapy in the management of LUTS due to BPH in men attending a tertiary hospital in Ghana.

Methods: This prospective, randomized, open-label study was conducted over 12 weeks at the Korle-Bu Teaching Hospital. Eighty-two men aged ⩾40 years with moderate to severe LUTS due to BPH were randomized to receive either tadalafil 5 mg or tamsulosin 0.4 mg daily. Baseline, 4-week, and 12-week evaluations included International Prostate Symptom Score (IPSS), quality of life (QoL), peak urinary flow rate (Qmax), post-void residual urine (PVR), and International Index of Erectile Function (IIEF-5). Statistical analyses included t-tests and linear regression.

Results: Both groups showed significant improvement in IPSS, QoL, Qmax, and PVR over time. At 12 weeks, Qmax was significantly higher in the tadalafil group compared to tamsulosin (18.7 ± 4.5 vs 16.9 ± 2.6 mL/s, p = 0.045). IPSS improvement was similar across both arms (Tadalafil: -9.3; Tamsulosin: -7.8). Tadalafil significantly improved IIEF-5 scores from 14.0 to 21.0 (p < 0.001), whereas tamsulosin showed minimal change. Subgroup analysis showed tadalafil's erectile function benefit was consistent across demographic and clinical subgroups except in diabetics. Side effects were mild (5.1%) and equally distributed between groups.

Conclusion: Tadalafil and tamsulosin are both effective in alleviating LUTS due to BPH. Tadalafil provides additional benefits in erectile function and superior improvement in urinary flow, making it a suitable first-line option, especially for patients with coexisting ED. These findings support individualized treatment decisions based on patient profile and symptom burden in resource-limited settings.

背景:良性前列腺增生(BPH)通常表现为下尿路症状(LUTS),这会严重影响老年男性的生活质量。坦索罗辛是一种选择性α -1阻滞剂,广泛用于缓解症状。他达拉非是一种磷酸二酯酶-5抑制剂,对LUTS和勃起功能障碍(ED)有双重疗效。然而,非洲人口的比较数据有限。目的:比较他达拉非和坦索罗辛单药治疗在加纳某三级医院就诊的男性前列腺增生引起的LUTS的疗效和安全性。方法:这项前瞻性、随机、开放标签研究在Korle-Bu教学医院进行了超过12周的研究。82名年龄大于或等于40岁的男性因BPH而患有中度至重度LUTS,随机接受每日5毫克的他达拉非或0.4毫克的坦索罗辛。基线、4周和12周的评估包括国际前列腺症状评分(IPSS)、生活质量(QoL)、峰值尿流率(Qmax)、空后残留尿(PVR)和国际勃起功能指数(IIEF-5)。统计分析包括t检验和线性回归。结果:两组患者IPSS、QoL、Qmax、PVR均随时间改善。12周时,他达拉非组Qmax显著高于坦索罗辛组(18.7±4.5 vs 16.9±2.6 mL/s, p = 0.045)。两组IPSS改善情况相似(他达拉非:-9.3;坦索罗辛:-7.8)。他达拉非可显著提高IIEF-5评分,由14.0分提高至21.0分(p)。结论:他达拉非与坦索罗辛均可有效缓解BPH所致LUTS。他达拉非在勃起功能和尿流改善方面提供了额外的益处,使其成为一个合适的一线选择,特别是对于合并ED的患者。这些研究结果支持在资源有限的情况下,基于患者概况和症状负担的个性化治疗决策。
{"title":"Tadalafil and tamsulosin in the management of lower urinary tract symptoms due to benign prostatic hyperplasia: A prospective, randomized, open-label, comparative study.","authors":"Enoch Tackie, Mathew Yamoah Kyei, James Edward Mensah","doi":"10.1177/03915603261421800","DOIUrl":"https://doi.org/10.1177/03915603261421800","url":null,"abstract":"<p><strong>Background: </strong>Benign prostatic hyperplasia (BPH) commonly presents with lower urinary tract symptoms (LUTS), which can significantly impair quality of life in aging men. Tamsulosin, a selective alpha-1 blocker, is widely used for symptom relief. Tadalafil, a phosphodiesterase-5 inhibitor, offers dual benefit for LUTS and erectile dysfunction (ED). However, limited comparative data exist from African populations.</p><p><strong>Objective: </strong>To compare the efficacy and safety of tadalafil and tamsulosin monotherapy in the management of LUTS due to BPH in men attending a tertiary hospital in Ghana.</p><p><strong>Methods: </strong>This prospective, randomized, open-label study was conducted over 12 weeks at the Korle-Bu Teaching Hospital. Eighty-two men aged ⩾40 years with moderate to severe LUTS due to BPH were randomized to receive either tadalafil 5 mg or tamsulosin 0.4 mg daily. Baseline, 4-week, and 12-week evaluations included International Prostate Symptom Score (IPSS), quality of life (QoL), peak urinary flow rate (Qmax), post-void residual urine (PVR), and International Index of Erectile Function (IIEF-5). Statistical analyses included t-tests and linear regression.</p><p><strong>Results: </strong>Both groups showed significant improvement in IPSS, QoL, Qmax, and PVR over time. At 12 weeks, Qmax was significantly higher in the tadalafil group compared to tamsulosin (18.7 ± 4.5 vs 16.9 ± 2.6 mL/s, <i>p</i> = 0.045). IPSS improvement was similar across both arms (Tadalafil: -9.3; Tamsulosin: -7.8). Tadalafil significantly improved IIEF-5 scores from 14.0 to 21.0 (<i>p</i> < 0.001), whereas tamsulosin showed minimal change. Subgroup analysis showed tadalafil's erectile function benefit was consistent across demographic and clinical subgroups except in diabetics. Side effects were mild (5.1%) and equally distributed between groups.</p><p><strong>Conclusion: </strong>Tadalafil and tamsulosin are both effective in alleviating LUTS due to BPH. Tadalafil provides additional benefits in erectile function and superior improvement in urinary flow, making it a suitable first-line option, especially for patients with coexisting ED. These findings support individualized treatment decisions based on patient profile and symptom burden in resource-limited settings.</p>","PeriodicalId":23574,"journal":{"name":"Urologia Journal","volume":" ","pages":"3915603261421800"},"PeriodicalIF":0.7,"publicationDate":"2026-02-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146202677","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Use of fibrin glue versus martius flap interposition in Trans-vaginal vesicovaginal fistula repair: A prospective randomized trial. 纤维蛋白胶与基质瓣介入经阴道膀胱阴道瘘修复:一项前瞻性随机试验。
IF 0.7 Q4 UROLOGY & NEPHROLOGY Pub Date : 2026-02-13 DOI: 10.1177/03915603261418997
Sunirmal Choudhury, Papiya Biswas, Prakhar Patel, Surajit Sasmal, Shahbaaz Ahmed

Introduction: In vesicovaginal fistula repair, studies have shown the utility of fibrin glue as interpositioning layer. Our goal in this study is to determine the effectiveness of fibrin glue as an interpositioning layer versus martius flap interposition and primary healing alone.

Materials and methods: We prospectively analyzed 64 patients over a period of 24 months from February, 2023 to January, 2025 and divided them as group-A in which fistulas were repaired anatomically using fibrin glue interpositioning, group-B in which fistulas were treated using only primary repair and group-C in which Martius flap was used during anatomical surgical repair as an intervening layer between the vaginal repair and bladder repair. The measured data included operative time, length of hospital stay, leak free status at POD 21, PISQ-12 (Pelvic Organ Prolapse/Urinary Incontinence Sexual Function Questionnaire) questionnaires and post-operative complications.

Results: The operative time was minimum in Group-B as compared to Group-A & C. (Group-A [183.64 ± 13.46 min.], Group-B [163.33 ± 14.60 min.] & Group-C [218.57 ± 24.75 min.]) which was significant (p = 0.000). The mean post operative hospital stay was minimum in Group-A, which were 7 ± 0.92, 8.19 ± 0.75 and 7.62 ± 0.74 days in A, B, and C groups (p = 0.01), respectively. Leak free status at POD-21 days after removal of catheter was comparable in Group-A & Group-C (Group-A was 90.9% vs 81% in Group-B vs 90.5% in Group-C) (p = 0.541). PISQ-12 in Group-A was 23.23 versus 23.76 in Group-B versus 22.14 in Group-C and which was significant (p = 0.002).

Conclusions: The study revealed that interposing layer in the form of glue is not an inferior option when compared to primary repair alone and martius flap as the total operative time, need for hospital stay and leak free status was comparable with lesser complications and comorbidities.

导言:在膀胱阴道瘘修复中,研究表明纤维蛋白胶作为间置层的应用价值。我们在这项研究中的目的是确定纤维蛋白胶作为间置层与单纯基质瓣间置和初级愈合的有效性。材料与方法:对2023年2月至2025年1月共24个月的64例患者进行前瞻性分析,将其分为a组,采用纤维蛋白胶夹层法解剖修复瘘管;b组,只进行初级修复;c组,在解剖外科修复中使用Martius瓣作为阴道修复和膀胱修复的中间层。测量数据包括手术时间、住院时间、pod21无漏状态、PISQ-12(盆腔器官脱垂/尿失禁性功能问卷)问卷和术后并发症。结果:b组手术时间较a、c组最短(a组为183.64±13.46 min);b组[163.33±14.60 min]。c组[218.57±24.75 min]。]),差异有统计学意义(p = 0.000)。A组患者术后平均住院时间最短,分别为(7±0.92)天、(8.19±0.75)天、(7.62±0.74)天(p = 0.01)。a组和c组在拔管后POD-21天无泄漏状态具有可比性(a组为90.9%,b组为81%,c组为90.5%)(p = 0.541)。a组PISQ-12为23.23,b组为23.76,c组为22.14,差异有统计学意义(p = 0.002)。结论:本研究表明,与单纯修复和软骨瓣相比,以胶的形式插入层并不是一种劣势的选择,因为总手术时间、住院时间和无泄漏状态相当,并发症和合并症较少。
{"title":"Use of fibrin glue versus martius flap interposition in Trans-vaginal vesicovaginal fistula repair: A prospective randomized trial.","authors":"Sunirmal Choudhury, Papiya Biswas, Prakhar Patel, Surajit Sasmal, Shahbaaz Ahmed","doi":"10.1177/03915603261418997","DOIUrl":"https://doi.org/10.1177/03915603261418997","url":null,"abstract":"<p><strong>Introduction: </strong>In vesicovaginal fistula repair, studies have shown the utility of fibrin glue as interpositioning layer. Our goal in this study is to determine the effectiveness of fibrin glue as an interpositioning layer versus martius flap interposition and primary healing alone.</p><p><strong>Materials and methods: </strong>We prospectively analyzed 64 patients over a period of 24 months from February, 2023 to January, 2025 and divided them as group-A in which fistulas were repaired anatomically using fibrin glue interpositioning, group-B in which fistulas were treated using only primary repair and group-C in which Martius flap was used during anatomical surgical repair as an intervening layer between the vaginal repair and bladder repair. The measured data included operative time, length of hospital stay, leak free status at POD 21, PISQ-12 (Pelvic Organ Prolapse/Urinary Incontinence Sexual Function Questionnaire) questionnaires and post-operative complications.</p><p><strong>Results: </strong>The operative time was minimum in Group-B as compared to Group-A & C. (Group-A [183.64 ± 13.46 min.], Group-B [163.33 ± 14.60 min.] & Group-C [218.57 ± 24.75 min.]) which was significant (<i>p</i> = 0.000). The mean post operative hospital stay was minimum in Group-A, which were 7 ± 0.92, 8.19 ± 0.75 and 7.62 ± 0.74 days in A, B, and C groups (<i>p</i> = 0.01), respectively. Leak free status at POD-21 days after removal of catheter was comparable in Group-A & Group-C (Group-A was 90.9% vs 81% in Group-B vs 90.5% in Group-C) (<i>p</i> = 0.541). <b>PISQ-12</b> in Group-A was 23.23 versus 23.76 in Group-B versus 22.14 in Group-C and which was significant (<b><i>p</i> = 0.002</b>).</p><p><strong>Conclusions: </strong>The study revealed that interposing layer in the form of glue is not an inferior option when compared to primary repair alone and martius flap as the total operative time, need for hospital stay and leak free status was comparable with lesser complications and comorbidities.</p>","PeriodicalId":23574,"journal":{"name":"Urologia Journal","volume":" ","pages":"3915603261418997"},"PeriodicalIF":0.7,"publicationDate":"2026-02-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146194666","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Multicenter study on the effectiveness of entomological extract-based therapy in men with lower urinary symptoms associated with benign prostatic hyperplasia and chronic prostatitis. 多中心研究昆虫提取物治疗与良性前列腺增生和慢性前列腺炎相关的男性下尿症状的有效性
IF 0.7 Q4 UROLOGY & NEPHROLOGY Pub Date : 2026-02-13 DOI: 10.1177/03915603261421805
George Kasyan, Lyubov Khodyreva, Bagrat Grigoryan, Vladimir Dyakov

Introduction and objectives: Benign prostatic hyperplasia (BPH) and chronic prostatitis (CP) are common causes of lower urinary tract symptoms (LUTS) in men. This multicenter study evaluated the efficacy of an entomological extract-based treatment (EEBT) as monotherapy and in combination with standard drugs.

Materials and methods: A total of 6375 men with LUTS (IPSS ⩾ 10, Qmax 5-15 mL/s) were included; 1498 had BPH, 3060 had CP, and 1817 had both. Group I received EEBT monotherapy, while Group II underwent combination therapy with α1-adrenergic blockers, NSAIDs, antibiotics, and other agents. Outcomes were assessed after 30 days using NIH-CPSI, IPSS, IIEF-5, QoL, Qmax, prostate volume, and residual urine.

Results: Both regimens significantly improved LUTS. In BPH patients, monotherapy reduced prostate and residual urine volumes and improved IIEF-5, whereas combination therapy provided greater symptom relief. In CP patients, both regimens improved NIH-CPSI, IPSS, and urinary flow, with monotherapy showing superior QoL benefits. In men with BPH + CP, monotherapy favored erectile function, while combination therapy improved IPSS. All subgroups demonstrated significant gains in Qmax. Treatment was well tolerated; only mild Clavien-Dindo grade I and II adverse events were reported, with no serious complications.

Conclusion: EEBT is effective as both monotherapy and in combination therapy for LUTS associated with BPH and CP, supporting its role in personalized treatment strategies.

简介和目的:良性前列腺增生(BPH)和慢性前列腺炎(CP)是男性下尿路症状(LUTS)的常见原因。这项多中心研究评估了昆虫提取物治疗(EEBT)作为单一疗法和与标准药物联合治疗的疗效。材料和方法:共纳入6375名LUTS (IPSS小于10,Qmax 5-15 mL/s)的男性;1498人有BPH, 3060人有CP, 1817人两者都有。ⅰ组采用EEBT单药治疗,ⅱ组采用α - 1肾上腺素能阻滞剂、非甾体抗炎药、抗生素等药物联合治疗。30天后使用NIH-CPSI、IPSS、IIEF-5、QoL、Qmax、前列腺体积和残余尿评估结果。结果:两种方案均显著改善了LUTS。在BPH患者中,单药治疗减少了前列腺和残余尿量,改善了IIEF-5,而联合治疗提供了更大的症状缓解。在CP患者中,两种方案都改善了NIH-CPSI、IPSS和尿流,单药治疗显示出更好的生活质量。在BPH + CP的男性中,单药治疗有利于勃起功能,而联合治疗可改善IPSS。所有亚组的Qmax均有显著提高。治疗耐受性良好;仅报告轻度Clavien-Dindo I级和II级不良事件,无严重并发症。结论:ebt对合并BPH和CP的LUTS单药和联合治疗均有效,支持其在个性化治疗策略中的作用。
{"title":"Multicenter study on the effectiveness of entomological extract-based therapy in men with lower urinary symptoms associated with benign prostatic hyperplasia and chronic prostatitis.","authors":"George Kasyan, Lyubov Khodyreva, Bagrat Grigoryan, Vladimir Dyakov","doi":"10.1177/03915603261421805","DOIUrl":"https://doi.org/10.1177/03915603261421805","url":null,"abstract":"<p><strong>Introduction and objectives: </strong>Benign prostatic hyperplasia (BPH) and chronic prostatitis (CP) are common causes of lower urinary tract symptoms (LUTS) in men. This multicenter study evaluated the efficacy of an entomological extract-based treatment (EEBT) as monotherapy and in combination with standard drugs.</p><p><strong>Materials and methods: </strong>A total of 6375 men with LUTS (IPSS ⩾ 10, Qmax 5-15 mL/s) were included; 1498 had BPH, 3060 had CP, and 1817 had both. Group I received EEBT monotherapy, while Group II underwent combination therapy with α1-adrenergic blockers, NSAIDs, antibiotics, and other agents. Outcomes were assessed after 30 days using NIH-CPSI, IPSS, IIEF-5, QoL, Qmax, prostate volume, and residual urine.</p><p><strong>Results: </strong>Both regimens significantly improved LUTS. In BPH patients, monotherapy reduced prostate and residual urine volumes and improved IIEF-5, whereas combination therapy provided greater symptom relief. In CP patients, both regimens improved NIH-CPSI, IPSS, and urinary flow, with monotherapy showing superior QoL benefits. In men with BPH + CP, monotherapy favored erectile function, while combination therapy improved IPSS. All subgroups demonstrated significant gains in Qmax. Treatment was well tolerated; only mild Clavien-Dindo grade I and II adverse events were reported, with no serious complications.</p><p><strong>Conclusion: </strong>EEBT is effective as both monotherapy and in combination therapy for LUTS associated with BPH and CP, supporting its role in personalized treatment strategies.</p>","PeriodicalId":23574,"journal":{"name":"Urologia Journal","volume":" ","pages":"3915603261421805"},"PeriodicalIF":0.7,"publicationDate":"2026-02-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146195757","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Safety and efficacy of retrograde intrarenal surgery (RIRS) in pediatric patients: Insights from a single-center study. 儿科患者逆行肾内手术(RIRS)的安全性和有效性:来自单中心研究的见解
IF 0.7 Q4 UROLOGY & NEPHROLOGY Pub Date : 2026-02-08 DOI: 10.1177/03915603261419000
Nadeem Bin Nusrat, Assad Ur Rehman, Shujah Muhammad, Nauman Zafar, Sarmad Imtiaz, Saud Iqbal, Saira Imtiaz

Background: Pediatric urolithiasis is increasingly managed with minimally invasive approaches. Retrograde Intrarenal Surgery (RIRS) offers a promising treatment option, though data on its outcomes in children remain limited.

Objective: To evaluate the safety, efficacy, and predictors of outcomes following Retrograde Intrarenal Surgery (RIRS) in pediatric patients with renal or upper urinary tract stones.

Methods: From September 2022 to August 2024, retrospective observational research was carried out at the Pakistan Kidney and Liver Institute and Research Center in Lahore. Included were pediatric patients (less than 14 years old) who had RIRS for upper tract or renal stones up to 27 mm. Demographics, stone features, surgical parameters, complications, and follow-up imaging results were among the data that were taken from electronic medical records. Statistical analysis was performed using SPSS v27; multivariate logistic regression identified predictors of postoperative complications and stone clearance.

Results: A total of 24 pediatric patients underwent RIRS. Mean age was 9.0 ± 4.27 years; 18 (75.0%) were male. Stones were more often left-sided (14/24, 58.3%) and commonly located at multiple sites (11/24, 45.8%). RIRS was the primary treatment in 17 (70.8%) patients. Complete stone clearance was achieved in 17 (70.8%); access failure occurred in 4 (16.7%). Postoperative complications occurred in 5 (20.8%), including sepsis in 4 (16.7%). Anatomical abnormalities were seen in 5 (20.8%). Multivariate analysis showed anatomical abnormalities were protective against complications (p = 0.037), while stone size >15 mm significantly reduced clearance odds (p = 0.009). The predictive model for clearance was significant (p = 0.013, R2 = 0.519).

Conclusion: RIRS is a safe and effective treatment modality for pediatric urolithiasis, achieving high stone-free rate with minimal complications. Anatomical abnormalities may reduce risk of complications, while larger stone size negatively impacts clearance. These findings support the selective use of RIRS in children with careful preoperative evaluation to optimize outcomes.

背景:小儿尿石症越来越多地采用微创方法治疗。逆行肾内手术(RIRS)提供了一个很有希望的治疗选择,尽管其在儿童中的结果数据仍然有限。目的:评价儿童肾或上尿路结石患者行逆行肾内手术(RIRS)的安全性、有效性和预后预测因素。方法:于2022年9月至2024年8月在拉合尔巴基斯坦肾脏和肝脏研究所和研究中心进行回顾性观察研究。纳入的儿童患者(小于14岁)为上尿路结石或肾结石达27毫米的RIRS。从电子病历中获取的数据包括人口统计学、结石特征、手术参数、并发症和随访影像结果。采用SPSS v27进行统计学分析;多因素logistic回归确定了术后并发症和结石清除的预测因素。结果:共有24例儿童患者接受了RIRS。平均年龄9.0±4.27岁;男性18例(75.0%)。结石多见于左侧(14/24,58.3%),多处多发(11/24,45.8%)。RIRS是17例(70.8%)患者的主要治疗方法。17例(70.8%)结石完全清除;访问失败4例(16.7%)。术后并发症5例(20.8%),脓毒症4例(16.7%)。解剖异常5例(20.8%)。多因素分析显示,解剖异常对并发症有保护作用(p = 0.037),而结石大小bbb15 mm显著降低清除几率(p = 0.009)。清除率预测模型显著(p = 0.013, R2 = 0.519)。结论:RIRS是一种安全有效的治疗小儿尿石症的方法,结石清除率高,并发症少。解剖异常可能会降低并发症的风险,而较大的结石会对清除产生负面影响。这些发现支持在儿童中选择性地使用RIRS,并进行仔细的术前评估以优化结果。
{"title":"Safety and efficacy of retrograde intrarenal surgery (RIRS) in pediatric patients: Insights from a single-center study.","authors":"Nadeem Bin Nusrat, Assad Ur Rehman, Shujah Muhammad, Nauman Zafar, Sarmad Imtiaz, Saud Iqbal, Saira Imtiaz","doi":"10.1177/03915603261419000","DOIUrl":"https://doi.org/10.1177/03915603261419000","url":null,"abstract":"<p><strong>Background: </strong>Pediatric urolithiasis is increasingly managed with minimally invasive approaches. Retrograde Intrarenal Surgery (RIRS) offers a promising treatment option, though data on its outcomes in children remain limited.</p><p><strong>Objective: </strong>To evaluate the safety, efficacy, and predictors of outcomes following Retrograde Intrarenal Surgery (RIRS) in pediatric patients with renal or upper urinary tract stones.</p><p><strong>Methods: </strong>From September 2022 to August 2024, retrospective observational research was carried out at the Pakistan Kidney and Liver Institute and Research Center in Lahore. Included were pediatric patients (less than 14 years old) who had RIRS for upper tract or renal stones up to 27 mm. Demographics, stone features, surgical parameters, complications, and follow-up imaging results were among the data that were taken from electronic medical records. Statistical analysis was performed using SPSS v27; multivariate logistic regression identified predictors of postoperative complications and stone clearance.</p><p><strong>Results: </strong>A total of 24 pediatric patients underwent RIRS. Mean age was 9.0 ± 4.27 years; 18 (75.0%) were male. Stones were more often left-sided (14/24, 58.3%) and commonly located at multiple sites (11/24, 45.8%). RIRS was the primary treatment in 17 (70.8%) patients. Complete stone clearance was achieved in 17 (70.8%); access failure occurred in 4 (16.7%). Postoperative complications occurred in 5 (20.8%), including sepsis in 4 (16.7%). Anatomical abnormalities were seen in 5 (20.8%). Multivariate analysis showed anatomical abnormalities were protective against complications (<i>p</i> = 0.037), while stone size >15 mm significantly reduced clearance odds (<i>p</i> = 0.009). The predictive model for clearance was significant (<i>p</i> = 0.013, <i>R</i><sup>2</sup> = 0.519).</p><p><strong>Conclusion: </strong>RIRS is a safe and effective treatment modality for pediatric urolithiasis, achieving high stone-free rate with minimal complications. Anatomical abnormalities may reduce risk of complications, while larger stone size negatively impacts clearance. These findings support the selective use of RIRS in children with careful preoperative evaluation to optimize outcomes.</p>","PeriodicalId":23574,"journal":{"name":"Urologia Journal","volume":" ","pages":"3915603261419000"},"PeriodicalIF":0.7,"publicationDate":"2026-02-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146143360","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Outcomes and management of de novo ureteral strictures following ureteroscopy: A retrospective observational study. 输尿管镜术后新发输尿管狭窄的结局和处理:一项回顾性观察研究。
IF 0.7 Q4 UROLOGY & NEPHROLOGY Pub Date : 2026-02-08 DOI: 10.1177/03915603261418995
Anette Nyheim, Øyvind Ulvik, Christian Beisland, Patrick Juliebø-Jones

Introduction: Ureteral strictures are a recognised late complication post ureteroscopy (URS). Most research on the pathology focuses on mechanisms of injury and preventative strategies. There is limited data describing follow up patterns and treatment outcomes. The aim was to evaluate the subsequent management and outcomes of de novo ureteral strictures post URS.

Methods: Retrospective review was conducted of patients diagnosed with a de novo ureteral stricture post URS at a tertiary centre between 2014 and 2024. Eligible cases were identified by manual review of ICD-coded records (N13.0-N13.5), yielding 40 patients for analysis. Baseline and procedural data were summarised descriptively, and group comparisons were performed using the Mann-Whitney U and Fisher's exact tests.

Results: Among 40 patients (median age 69 years), most strictures were detected symptomatically (67.5%) and were located proximally or distally (each 43%). Median time to diagnosis was 3.8 months, and median follow-up was 4.3 years. Overall, 45% achieved successful resolution after a median of two procedures, while 15% underwent nephrectomy. Higher age-adjusted Charlson Comorbidity Index scores and older age were significantly associated with poorer outcomes, although interpretation is limited by the sample size. Stricture length and a history of stone impaction showed no significant associations.

Conclusions: In this cohort, fewer than half of patients with de novo ureteral strictures following URS achieved lasting resolution despite multiple interventions. These findings highlight the potential clinical burden of this complication and support the importance of preventive strategies, timely detection and structured follow-up, while underscoring the need for further studies to better define long-term outcomes.

导读:输尿管狭窄是输尿管镜检查(URS)后公认的晚期并发症。大多数病理学研究集中在损伤机制和预防策略上。描述随访模式和治疗结果的数据有限。目的是评估尿路重尿后新发输尿管狭窄的后续处理和结果。方法:回顾性分析2014年至2024年在某三级中心诊断为尿毒症后新发输尿管狭窄的患者。通过人工审查icd编码记录(N13.0-N13.5)确定符合条件的病例,产生40例患者用于分析。对基线和程序数据进行描述性总结,并使用Mann-Whitney U和Fisher精确检验进行组间比较。结果:40例患者(中位年龄69岁)中,大多数狭窄有症状(67.5%),位于近端或远端(各43%)。中位诊断时间为3.8个月,中位随访时间为4.3年。总的来说,45%的患者在平均两次手术后获得了成功的解决,而15%的患者接受了肾切除术。年龄调整后的Charlson共病指数得分越高,年龄越大,结果越差,尽管解释受到样本量的限制。狭窄长度与结石嵌塞史无显著相关性。结论:在这个队列中,尽管采取了多种干预措施,但只有不到一半的尿潴留后新发输尿管狭窄患者获得了持久的缓解。这些发现强调了该并发症的潜在临床负担,并支持预防策略、及时发现和有组织的随访的重要性,同时强调了进一步研究以更好地确定长期结果的必要性。
{"title":"Outcomes and management of de novo ureteral strictures following ureteroscopy: A retrospective observational study.","authors":"Anette Nyheim, Øyvind Ulvik, Christian Beisland, Patrick Juliebø-Jones","doi":"10.1177/03915603261418995","DOIUrl":"https://doi.org/10.1177/03915603261418995","url":null,"abstract":"<p><strong>Introduction: </strong>Ureteral strictures are a recognised late complication post ureteroscopy (URS). Most research on the pathology focuses on mechanisms of injury and preventative strategies. There is limited data describing follow up patterns and treatment outcomes. The aim was to evaluate the subsequent management and outcomes of de novo ureteral strictures post URS.</p><p><strong>Methods: </strong>Retrospective review was conducted of patients diagnosed with a de novo ureteral stricture post URS at a tertiary centre between 2014 and 2024. Eligible cases were identified by manual review of ICD-coded records (N13.0-N13.5), yielding 40 patients for analysis. Baseline and procedural data were summarised descriptively, and group comparisons were performed using the Mann-Whitney U and Fisher's exact tests.</p><p><strong>Results: </strong>Among 40 patients (median age 69 years), most strictures were detected symptomatically (67.5%) and were located proximally or distally (each 43%). Median time to diagnosis was 3.8 months, and median follow-up was 4.3 years. Overall, 45% achieved successful resolution after a median of two procedures, while 15% underwent nephrectomy. Higher age-adjusted Charlson Comorbidity Index scores and older age were significantly associated with poorer outcomes, although interpretation is limited by the sample size. Stricture length and a history of stone impaction showed no significant associations.</p><p><strong>Conclusions: </strong>In this cohort, fewer than half of patients with de novo ureteral strictures following URS achieved lasting resolution despite multiple interventions. These findings highlight the potential clinical burden of this complication and support the importance of preventive strategies, timely detection and structured follow-up, while underscoring the need for further studies to better define long-term outcomes.</p>","PeriodicalId":23574,"journal":{"name":"Urologia Journal","volume":" ","pages":"3915603261418995"},"PeriodicalIF":0.7,"publicationDate":"2026-02-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146143724","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Monopolar electrocautery in providing hemostasis of the percutaneous tract during tubeless miniature percutaneous nephrolithotomy. 单极电灼在无管微型经皮肾镜取石术中提供经皮道止血的作用。
IF 0.7 Q4 UROLOGY & NEPHROLOGY Pub Date : 2026-02-08 DOI: 10.1177/03915603261418998
Chinnakhet Ketsuwan, Hyeji Park, Christine Joy G Castillo, Majed Alharthi, Sung Yong Cho

Introduction: Kidney hemorrhage is one of the most common and significant complications of percutaneous approaches for renal stone removal. This study evaluated the effectiveness and safety of hemostatic completion in minimally invasive percutaneous nephrolithotomy (mini-PCNL) using monopolar electrocautery in patients with intrarenal tract bleeding.

Materials and methods: We prospectively investigated 200 consecutive patients presenting to a single institution and classified them into two groups. The experimental group consisted of 28 patients receiving monopolar coagulation for intrarenal bleeders in the percutaneous tract. The control group included 172 patients in whom fulguration was not done. Perioperative outcomes were compared between the groups.

Results: The two groups had no statistical difference in operative times and transfusion rates. Patients who received electrocauterization demonstrated a significantly shortened duration of double J stent removal (p = 0.011), more rapid recovery of hemoglobin levels, particularly in cases of significant bleeding (p < 0.001), and a lower rate of angiography (p = 0.047). No embolization was needed in the electrocauterization group. No significant complications were observed in either group.

Conclusions: These findings suggest that monopolar electrocautery might effectively reduce the risk of postoperative bleeding and alleviate the burden on patients who may require additional blood transfusions in patients undergoing tubeless mini-PCNL.

导读:肾出血是经皮肾结石取石术中最常见和最重要的并发症之一。本研究评估了单极电灼微创经皮肾镜取石术(mini-PCNL)治疗肾内出血患者止血完成的有效性和安全性。材料和方法:我们前瞻性地调查了200例在同一机构就诊的连续患者,并将其分为两组。实验组28例经皮路肾内出血接受单极凝固治疗。对照组172例患者不进行电灼治疗。比较两组围手术期疗效。结果:两组患者手术次数、输血率差异无统计学意义。接受电灼治疗的患者双J型支架取出时间明显缩短(p = 0.011),血红蛋白水平恢复更快,特别是在明显出血的情况下(p p = 0.047)。电烧灼组不需要栓塞。两组均未见明显并发症。结论:本研究结果提示单极电灼可有效降低无管迷你pcnl患者术后出血的风险,减轻患者可能需要额外输血的负担。
{"title":"Monopolar electrocautery in providing hemostasis of the percutaneous tract during tubeless miniature percutaneous nephrolithotomy.","authors":"Chinnakhet Ketsuwan, Hyeji Park, Christine Joy G Castillo, Majed Alharthi, Sung Yong Cho","doi":"10.1177/03915603261418998","DOIUrl":"https://doi.org/10.1177/03915603261418998","url":null,"abstract":"<p><strong>Introduction: </strong>Kidney hemorrhage is one of the most common and significant complications of percutaneous approaches for renal stone removal. This study evaluated the effectiveness and safety of hemostatic completion in minimally invasive percutaneous nephrolithotomy (mini-PCNL) using monopolar electrocautery in patients with intrarenal tract bleeding.</p><p><strong>Materials and methods: </strong>We prospectively investigated 200 consecutive patients presenting to a single institution and classified them into two groups. The experimental group consisted of 28 patients receiving monopolar coagulation for intrarenal bleeders in the percutaneous tract. The control group included 172 patients in whom fulguration was not done. Perioperative outcomes were compared between the groups.</p><p><strong>Results: </strong>The two groups had no statistical difference in operative times and transfusion rates. Patients who received electrocauterization demonstrated a significantly shortened duration of double J stent removal (<i>p</i> = 0.011), more rapid recovery of hemoglobin levels, particularly in cases of significant bleeding (<i>p</i> < 0.001), and a lower rate of angiography (<i>p</i> = 0.047). No embolization was needed in the electrocauterization group. No significant complications were observed in either group.</p><p><strong>Conclusions: </strong>These findings suggest that monopolar electrocautery might effectively reduce the risk of postoperative bleeding and alleviate the burden on patients who may require additional blood transfusions in patients undergoing tubeless mini-PCNL.</p>","PeriodicalId":23574,"journal":{"name":"Urologia Journal","volume":" ","pages":"3915603261418998"},"PeriodicalIF":0.7,"publicationDate":"2026-02-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146143735","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Evaluating the accuracy and reliability of overactive bladder-related YouTube videos: A digital health quality analysis using DISCERN and GQS tools. 评估与膀胱过度活跃相关的YouTube视频的准确性和可靠性:使用DISCERN和GQS工具的数字健康质量分析。
IF 0.7 Q4 UROLOGY & NEPHROLOGY Pub Date : 2026-02-08 DOI: 10.1177/03915603261418195
Basri Cakiroglu, Ali Egemen Avci

Background: Overactive bladder (OAB) is a prevalent condition, and patients increasingly turn to online platforms such as YouTube for information, raising concerns about accuracy and reliability.

Purpose: This study aimed to evaluate the quality and reliability of YouTube videos related to overactive bladder (OAB) using two validated instruments: the DISCERN tool and the Global Quality Scale (GQS).

Methods: A systematic and structured YouTube search strategy, adapted from systematic review methodology but tailored for digital platforms, was conducted using the keyword overactive bladder. The first 100 videos retrieved were screened, and 60 met the inclusion criteria: English language, duration of at least 60 s, and relevant educational content. Exclusion criteria included non-English language, duplicates, advertisements, and purely promotional material. Two independent urologists evaluated each video using the DISCERN tool (range: 16-80) and GQS (range: 1-5). Additional data collected included video length, view count, uploader type, and thematic content. Descriptive statistics and correlation analyses were performed.

Results: The median video duration was 5.6 min (IQR: 3.4-8.2), with a median view count of 34,200 (IQR: 12,500-89,000). The mean DISCERN and GQS scores were 45.2 ± 10.1 and 2.9 ± 0.8, respectively, indicating moderate overall quality. Videos uploaded by healthcare professionals or institutions had significantly higher DISCERN and GQS scores compared to those uploaded by individuals or commercial entities (p < 0.001). Only 28% of videos addressed neurogenic causes of OAB, and 41% did not mention behavioral therapy. A weak but statistically significant positive correlation was observed between GQS score and view count (ρ = 0.34, p = 0.01).

Conclusions: YouTube contains a wide array of OAB-related videos, but their quality and reliability vary considerably. While some content is accurate and informative, significant gaps remain, particularly regarding neurogenic etiologies and behavioral management. Healthcare professionals should guide patients toward trustworthy resources and consider producing evidence-based content to improve digital health literacy.

背景:膀胱过动症(OAB)是一种普遍的疾病,患者越来越多地转向YouTube等在线平台获取信息,这引起了人们对准确性和可靠性的担忧。目的:本研究旨在使用两种经过验证的工具:DISCERN工具和全球质量量表(GQS)来评估与膀胱过度活动(OAB)相关的YouTube视频的质量和可靠性。方法:采用系统评价方法,针对数字平台进行系统化结构化的YouTube搜索策略,使用关键词膀胱过度活动。对检索到的前100个视频进行筛选,其中60个符合纳入标准:英语,时长至少60秒,并有相关的教育内容。排除标准包括非英语语言、重复、广告和纯粹的宣传材料。两位独立的泌尿科医生使用DISCERN工具(范围:16-80)和GQS(范围:1-5)对每个视频进行评估。收集的其他数据包括视频长度、观看次数、上传者类型和主题内容。进行描述性统计和相关分析。结果:视频时长中位数为5.6 min (IQR: 3.4-8.2),观看次数中位数为34,200次(IQR: 12,500-89,000)。平均DISCERN和GQS评分分别为45.2±10.1和2.9±0.8,总体质量中等。医疗专业人员或机构上传的视频的DISCERN和GQS得分显著高于个人或商业实体上传的视频(p p = 0.01)。结论:YouTube包含大量与oab相关的视频,但它们的质量和可靠性差异很大。虽然有些内容是准确和翔实的,但仍然存在重大差距,特别是在神经源性病因和行为管理方面。医疗保健专业人员应引导患者使用可信赖的资源,并考虑制作基于证据的内容,以提高数字健康素养。
{"title":"Evaluating the accuracy and reliability of overactive bladder-related YouTube videos: A digital health quality analysis using DISCERN and GQS tools.","authors":"Basri Cakiroglu, Ali Egemen Avci","doi":"10.1177/03915603261418195","DOIUrl":"https://doi.org/10.1177/03915603261418195","url":null,"abstract":"<p><strong>Background: </strong>Overactive bladder (OAB) is a prevalent condition, and patients increasingly turn to online platforms such as YouTube for information, raising concerns about accuracy and reliability.</p><p><strong>Purpose: </strong>This study aimed to evaluate the quality and reliability of YouTube videos related to overactive bladder (OAB) using two validated instruments: the DISCERN tool and the Global Quality Scale (GQS).</p><p><strong>Methods: </strong>A systematic and structured YouTube search strategy, adapted from systematic review methodology but tailored for digital platforms, was conducted using the keyword overactive bladder. The first 100 videos retrieved were screened, and 60 met the inclusion criteria: English language, duration of at least 60 s, and relevant educational content. Exclusion criteria included non-English language, duplicates, advertisements, and purely promotional material. Two independent urologists evaluated each video using the DISCERN tool (range: 16-80) and GQS (range: 1-5). Additional data collected included video length, view count, uploader type, and thematic content. Descriptive statistics and correlation analyses were performed.</p><p><strong>Results: </strong>The median video duration was 5.6 min (IQR: 3.4-8.2), with a median view count of 34,200 (IQR: 12,500-89,000). The mean DISCERN and GQS scores were 45.2 ± 10.1 and 2.9 ± 0.8, respectively, indicating moderate overall quality. Videos uploaded by healthcare professionals or institutions had significantly higher DISCERN and GQS scores compared to those uploaded by individuals or commercial entities (<i>p</i> < 0.001). Only 28% of videos addressed neurogenic causes of OAB, and 41% did not mention behavioral therapy. A weak but statistically significant positive correlation was observed between GQS score and view count (ρ = 0.34, <i>p</i> = 0.01).</p><p><strong>Conclusions: </strong>YouTube contains a wide array of OAB-related videos, but their quality and reliability vary considerably. While some content is accurate and informative, significant gaps remain, particularly regarding neurogenic etiologies and behavioral management. Healthcare professionals should guide patients toward trustworthy resources and consider producing evidence-based content to improve digital health literacy.</p>","PeriodicalId":23574,"journal":{"name":"Urologia Journal","volume":" ","pages":"3915603261418195"},"PeriodicalIF":0.7,"publicationDate":"2026-02-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146143704","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Comments on "Severe bleeding in patients following "tubeless" percutaneous nephrolithotomy: Predictors of angioembolization". 评论“无管经皮肾镜取石术后患者严重出血:血管栓塞的预测因素”。
IF 0.7 Q4 UROLOGY & NEPHROLOGY Pub Date : 2026-02-08 DOI: 10.1177/03915603261420375
Ankur Sharma, Sushma Narsing Katkuri, Varshini Vadhithala, Arun Kumar, Sushma Verma, Dhanya Dedeepya
{"title":"Comments on \"Severe bleeding in patients following \"tubeless\" percutaneous nephrolithotomy: Predictors of angioembolization\".","authors":"Ankur Sharma, Sushma Narsing Katkuri, Varshini Vadhithala, Arun Kumar, Sushma Verma, Dhanya Dedeepya","doi":"10.1177/03915603261420375","DOIUrl":"https://doi.org/10.1177/03915603261420375","url":null,"abstract":"","PeriodicalId":23574,"journal":{"name":"Urologia Journal","volume":" ","pages":"3915603261420375"},"PeriodicalIF":0.7,"publicationDate":"2026-02-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146143749","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Urologia Journal
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1